Literature DB >> 14611843

Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds.

Katsuhiro Okuda1, Yaichiro Kotake, Shigeru Ohta.   

Abstract

1-Methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) 1 and various 5- or 6,7-substituted analogues were synthesized and assayed for neurotoxicity towards SH-SY5Y cells. Among mono-substituted derivatives of 1, hydroxyl substitution decreased the toxicity, while methoxyl substitution increased it. Disubstituted derivatives of 1, 5a and 5b, showed the opposite tendency. Hydroxy-1MeTIQ derivatives were tested for neuroprotective activity, and 3b and 4b exhibited greater efficacy than 1. We suggest that hydroxy-1MeTIQ derivatives, especially 4b, may have potential for the treatment of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611843     DOI: 10.1016/s0960-894x(03)00583-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Isolation, synthesis, and biological activity of aphrocallistin, an adenine-substituted bromotyramine metabolite from the Hexactinellida sponge Aphrocallistes beatrix.

Authors:  Amy E Wright; Gregory P Roth; Jennifer K Hoffman; Daniela B Divlianska; Diana Pechter; Susan H Sennett; Esther A Guzmán; Patricia Linley; Peter J McCarthy; Tara P Pitts; Shirley A Pomponi; John K Reed
Journal:  J Nat Prod       Date:  2009-06       Impact factor: 4.050

2.  Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents.

Authors:  Yang Yang; Wei Ang; Haiyue Long; Ying Chang; Zicheng Li; Liangxue Zhou; Tao Yang; Yong Deng; Youfu Luo
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.